HCD/HCP

Mycoplasma qPCR detection and method validation contribute to the advancement of cell and gene therapy technology development

Mycoplasma qPCR detection and method validation contribute to the advancement of cell and gene therapy technology development

In recent years, with the rapid development of biomedicine, the emergence of cell and gene therapies under the COVID-19 pandemic, and the advent of...
Mycoplasma qPCR detection and method validation contribute to the advancement of cell and gene therapy technology development

Mycoplasma qPCR detection and method validation contribute to the advancement of cell and gene therapy technology development

In recent years, with the rapid development of biomedicine, the emergence of cell and gene therapies under the COVID-19 pandemic, and the advent of...
Host Cell Residual DNA Detection Kits facilitate Biologics R&D and Manufacturing

Host Cell Residual DNA Detection Kits facilitate Biologics R&D and Manufacturing

Host cell residual DNA is a process-related impurity involved in the production of biologics, which not only reduces the effectiveness of biologics...

Inquiry